Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CLONAZEPAM Cause Therapeutic response decreased? 141 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 141 reports of Therapeutic response decreased have been filed in association with CLONAZEPAM (Clonazepam). This represents 0.4% of all adverse event reports for CLONAZEPAM.

141
Reports of Therapeutic response decreased with CLONAZEPAM
0.4%
of all CLONAZEPAM reports
8
Deaths
25
Hospitalizations

How Dangerous Is Therapeutic response decreased From CLONAZEPAM?

Of the 141 reports, 8 (5.7%) resulted in death, 25 (17.7%) required hospitalization, and 1 (0.7%) were considered life-threatening.

Is Therapeutic response decreased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CLONAZEPAM. However, 141 reports have been filed with the FAERS database.

What Other Side Effects Does CLONAZEPAM Cause?

Drug ineffective (5,088) Toxicity to various agents (4,028) Completed suicide (3,320) Drug abuse (3,287) Off label use (2,590) Anxiety (2,376) Somnolence (2,260) Dyspnoea (1,987) Depression (1,838) Insomnia (1,836)

What Other Drugs Cause Therapeutic response decreased?

DUPILUMAB (7,824) ETANERCEPT (3,460) ONABOTULINUMTOXINA (2,685) METHOTREXATE (2,668) INFLIXIMAB (1,991) RITUXIMAB (1,728) LEFLUNOMIDE (1,574) TOCILIZUMAB (1,512) HYDROXYCHLOROQUINE (1,485) ADALIMUMAB (1,357)

Which CLONAZEPAM Alternatives Have Lower Therapeutic response decreased Risk?

CLONAZEPAM vs CLONIDINE CLONAZEPAM vs CLOPIDOGREL CLONAZEPAM vs CLOPIDOGREL BESILATE CLONAZEPAM vs CLOPIDOGREL BISULFATE CLONAZEPAM vs CLORAZEPATE

Related Pages

CLONAZEPAM Full Profile All Therapeutic response decreased Reports All Drugs Causing Therapeutic response decreased CLONAZEPAM Demographics